The Clinicopathologic Characteristics and 5-year Survival Rate of XXXX in Yazd, Iran.

@entity43 @entity1 @entity420 @entity5
INTRODUCTION: @entity43 is the second most common @entity5 in @entity1 , the most common cause of @entity5 deaths, and most @entity1 have advanced stage disease at the time of diagnosis. The purpose of this study was to estimate the 5-year survival of @entity1 with @entity43 based on age, @entity5 histology, stage of disease, and type of treatment. METHODS: This study was conducted on 120 @entity1 with @entity43 referred to Shahid Sadoughi hospital and Shah Vali oncology clinic of Yazd from 2006 to 2012. Demographic data and @entity1 records were studied to evaluate the treatment outcome, @entity5 , and stage of disease. Finally, the overall survival rate and @entity5 -free survival of @entity1 was assessed. RESULTS: The mean @entity1 age was 53.87   14.11 years. Most @entity1 had stage I (36.7%) or stage II (35%) disease. @entity420 (57.6%) was the most common pathology found in @entity1 with @entity43 . The overall survival of @entity1 in this study was significantly associated with the histological @entity5 type (p = 0.000) and disease stage (p = 0.0377). Stage I (84.18%) and @entity420 (72.81%) demonstrated the best survival. The @entity5 -free survival rates were not associated with histology types (p = 0.079), surgical procedure (p = 0.18), or chemotherapy (p = 0.18). CONCLUSION: The survival of @entity1 with @entity43 was significantly associated with disease stage. @entity420 also had the best prognosis among the pathologies studied. Therefore, early detection of @entity43 can substantially increase the survival rate.
